Synchronously, the RGS16 protein has been predicted to serve a central role in immune and inflammatory responses in addition to being a key member of the RGS family of oncogenes that contribute to the malignant progression of a number of human cancer types, but this remains to be further investigated (Xie et al., 2016). This evidence concerns the gene PITX2 and cancer.